Adare Pharmaceuticals: Optimizing therapeutic performance. Creating new possibilities for patients.

May 19, 2015

  When it comes to optimizing the therapeutic performance of oral drugs, customizing drug release profiles can provide a number of benefits, including improved efficacy, enhanced safety, and reduced dosing frequency. Adare has several proprietary technologies that can be used to customize drug release profiles and optimize the therapeutic performance of oral drugs.  

 

 

When it comes to optimizing the therapeutic performance of oral drugs, customizing drug release profiles can provide a number of benefits, including improved efficacy, enhanced safety, and reduced dosing frequency.

 

Adare has several proprietary technologies that can be used to customize drug release profiles and optimize the therapeutic performance of oral drugs.

 

Diffucaps® Customized Release Technology

This technology has the flexibility to incorporate functional, release-controlling polymers or protective coatings onto drug-layered cores, granules, or crystals. This multiparticulate system provides sophisticated control of drug delivery and optimizes release profiles for single drugs and drug combinations.

 

Examples of customized release particles

 

 

Eurand Minitabs® Controlled Release Technology

 

This technology combines the simplicity of a tablet formulation with the flexibility of multiparticulate dosage forms with high drug-loading capability. A significant advantage of Eurand Minitabs® technology is the ability for the patient or caregiver to open the capsule and sprinkle the contents on soft foods or add to a liquid. This is especially helpful for the pediatric patient, the elderly patient, or anyone who has difficulty swallowing.

 

With a broad range of proprietary technologies, Adare can help you overcome formulation challenges. To learn more, contact Lisa.Miller@adarepharma.com or visit www.AdarePharma.com 
 

©2015 Adare Pharmaceuticals, Inc.